期刊
JOURNAL OF BREAST CANCER
卷 15, 期 3, 页码 265-272出版社
KOREAN BREAST CANCER SOC
DOI: 10.4048/jbc.2012.15.3.265
关键词
Biomarker discovery; Breast neoplasms; Individualized medicine; Predictive biomarker; Prognostic biomarker
类别
The recent advent of -omics technologies have heralded a new era of personalized medicine. Personalized medicine is referred to as the ability to segment heterogeneous subsets of patients whose response to a therapeutic intervention within each subset is homogeneous. This new paradigm in healthcare is beginning to affect both research and clinical practice. The key to success in personalized medicine is to uncover molecular biomarkers that drive individual variability in clinical outcomes or drug responses. In this review, we begin with an overview of personalized medicine in breast cancer and illustrate the most encountered statistical approaches in the recent literature tailored for uncovering gene signatures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据